Dr. Kristina Rutkute serves as Director of Business Development of Albatroz Therapeutics. She started her career as a researcher in the field of cell signaling and later transitioned to management roles in Singapore-based start-ups Acumen Research Laboratories and Singapore Advanced Biologics. Kristina also managed a translational research programme which spanned projects from target discovery and validation to drug and clinical development at the National University of Singapore (NUS). Prior to joining Albatroz, Kristina conducted technology licensing and commercialisation of biotech innovation at the Agency of Science, Technology and Research (A*STAR), Singapore. She is also an MBA alumnus of the NUS Business School.